Novel pMDI formulations for pulmonary delivery of proteins

被引:40
|
作者
Li, Hao-Ying [1 ]
Seville, Peter C. [1 ]
机构
[1] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
基金
英国工程与自然科学研究理事会;
关键词
Sodium carboxymethylcellulose; HFA-134a; pMDI; Protein; Spray-drying; SPRAY-DRIED POWDERS; AEROSOLISATION PROPERTIES; STABILITY; TETRAFLUOROETHANE; PERFORMANCE; PARTICLES; CELLULOSE; POLYMERS; AEROSOLS; RELEASE;
D O I
10.1016/j.ijpharm.2009.10.032
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this paper, we demonstrate that co-spray-drying a model protein with sodium carboxymethylcellulose (NaCMC) protects protein integrity during spray-drying, and that the resultant spray-dried powders can be successfully dispersed in hydrofluoroalkane (HFA) propellant to prepare pressurised metered dose (pMDI) formulations that exhibit high respirable fractions. The spray-dried powders were formulated as HFA-134a pMDI suspensions in the absence of any other excipients (e.g. surfactants) or co-solvents (e.g ethanol). The in vitro aerosolisation profile of these systems was assessed using the twin stage impinger, fine particle fractions (FPF) >= 50% of the recovered dose were obtained. Following storage for five months, the aerosolisation performance was reassessed; the NaCMC-free formulation demonstrated a significant decrease in FPF, whereas the performance of the NaCMC-modified formulations was statistically equivalent to their initial performance. Thus, formulation of pMDI suspensions using NaCMC-based spray-dried powders is a promising approach for the pulmonary delivery of proteins and peptides. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条
  • [21] PULMONARY DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS
    ADJEI, A
    GUPTA, P
    JOURNAL OF CONTROLLED RELEASE, 1994, 29 (03) : 361 - 373
  • [22] Improved efficiency of pulmonary delivery of budesonide with Respimat® soft Mist™ inhaler compared with turbohaler or pMDI
    Wood, CC
    van Toor, B
    Hasselbarth, V
    Stammer, H
    Voss, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S82 - S82
  • [23] Inhaled formulations and pulmonary drug delivery systems for respiratory infections
    Zhou, Qi
    Leung, Sharon Shui Yee
    Tang, Patricia
    Parumasivam, Thaigarajan
    Loh, Zhi Hui
    Chan, Hak-Kim
    ADVANCED DRUG DELIVERY REVIEWS, 2015, 85 : 83 - 99
  • [24] Preparation of Nanoscale Pulmonary Drug Delivery Formulations by Spray Drying
    Bohr, Adam
    Ruge, Christian A.
    Beck-Broichsitter, Moritz
    NANOMATERIAL: IMPACTS ON CELL BIOLOGY AND MEDICINE, 2014, 811 : 183 - 206
  • [25] Recent Advances in Inhaled Formulations and Pulmonary Insulin Delivery Systems
    Liu, Haofan
    Shan, Xiaosong
    Yu, Jiaojiao
    Li, Xin
    Hu, Liandong
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2020, 21 (03) : 180 - 193
  • [26] SUSTAINED DELIVERY OF DETIRELIX AFTER PULMONARY ADMINISTRATION OF LIPOSOMAL FORMULATIONS
    BENNETT, DB
    TYSON, E
    MAH, S
    DEGROOT, JS
    HEGDE, SG
    TERAO, S
    TEITELBAUM, Z
    JOURNAL OF CONTROLLED RELEASE, 1994, 32 (01) : 27 - 35
  • [27] Dispersibility of spray-dried formulations for pulmonary drug delivery
    Li, H. -Y.
    Seville, P. C.
    Williamson, I. J.
    Birchall, J. C.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 : S9 - S10
  • [28] Surface energy and interparticle forces correlations in model pMDI formulations
    Traini, D
    Rogueda, P
    Young, P
    Price, R
    PHARMACEUTICAL RESEARCH, 2005, 22 (05) : 816 - 825
  • [29] Surface Energy and Interparticle Force Correlation in Model pMDI Formulations
    Daniela Traini
    Philippe Rogueda
    Paul Young
    Robert Price
    Pharmaceutical Research, 2005, 22 : 816 - 825
  • [30] Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis
    Parihar, Akshay
    Prajapati, Bhupendra G.
    Paliwal, Himanshu
    Shukla, Maheka
    Khunt, Dignesh
    Bahadure, Sumedh Devrao
    Dyawanapelly, Sathish
    Junnuthula, Vijayabhaskarreddy
    DRUG DISCOVERY TODAY, 2023, 28 (10)